Recurrent aphthous stomatitis is a common disorder characterized by recurring oral ulcers with no signs of systemic disease. It is caused by various factors like bacterial infection, immunologic abnormalities, nutritional deficiencies, trauma, and hormonal changes. Clinically, it presents as painful round or oval ulcers that heal within 2 weeks. It is classified into minor, major, and herpetiform types based on size, number, and site of ulcers. Treatment involves topical steroids, antimicrobial mouthwashes, analgesics, or intralesional steroid injections to reduce pain and promote healing.
A concise review on some conditions that cause epithelial erosion in the oral cavity.
This presentation covers some important lesions with clear diagrams for better comprehension.
A concise review on some conditions that cause epithelial erosion in the oral cavity.
This presentation covers some important lesions with clear diagrams for better comprehension.
A cyst is an epithelium-lined sac containing fluid or semisolid material. In the formation of a cyst, the epithelial cells first proliferate and later undergo degeneration and liquefaction. The liquefied material exerts equal pressure on the walls of the cyst from within. Cysts grow by expansion and thus displace the adjacent teeth by pressure. May can produce expansion of the cortical bone. On a radiograph, the radiolucency of a cyst is usually bordered by a radiopaque periphery of dense sclerotic bone. The radiolucency may be unilocular or multilocular. Odontogenic cysts are those which arise from the epithelium associated with the development of teeth. The source of epithelium is from the enamel organ, the reduced enamel epithelium, the cell rests of Malassez or the remnants of the dental lamina.
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.for more details please visit
www.indiandentalacademy.com
Dentists play an important role in the diagnosis and management of desquamative gingivitis. The importance of being able to recognise and properly diagnose this condition is accentuated by the fact that a serious and life threatening disease may initially manifest as desquamative gingivitis.
A cyst is an epithelium-lined sac containing fluid or semisolid material. In the formation of a cyst, the epithelial cells first proliferate and later undergo degeneration and liquefaction. The liquefied material exerts equal pressure on the walls of the cyst from within. Cysts grow by expansion and thus displace the adjacent teeth by pressure. May can produce expansion of the cortical bone. On a radiograph, the radiolucency of a cyst is usually bordered by a radiopaque periphery of dense sclerotic bone. The radiolucency may be unilocular or multilocular. Odontogenic cysts are those which arise from the epithelium associated with the development of teeth. The source of epithelium is from the enamel organ, the reduced enamel epithelium, the cell rests of Malassez or the remnants of the dental lamina.
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.for more details please visit
www.indiandentalacademy.com
Dentists play an important role in the diagnosis and management of desquamative gingivitis. The importance of being able to recognise and properly diagnose this condition is accentuated by the fact that a serious and life threatening disease may initially manifest as desquamative gingivitis.
The term “aphthous” is derived from a Greek word “aphtha” which means ulceration. Recurrent aphthous stomatitis (RAS) is one of the most common painful oral mucosal conditions seen among patients.
Granulomatous diseases of the head & neckMammootty Ik
covers all the important granulomatous diseases of head and neck region with a brief and to-the-point description of pathogenesis, clinical features , differential diagnosis and management of each disorder
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
4. DEFINITION OF ULCER
•ANY BREACH IN THE CONTINUITY OF
THE EPITHELIUM OF THE SKIN OR
MUCOUS MEMBRANE TO INVOLVE THE
UNDERLYING CONNECTIVE TISSUE AS
A RESULT OF MICROMOLECULAR CELL
DEATH OF SURFACE EPITHELIUM OR
ITS TRAUMATIC REMOVAL.
5. DEFINITION
It is a common disorder
characterized by recurring
ulcers confined to oral mucosa
with no other signs of
systemic diseases.
6. ETIOLOGY
BACTERIAL INFECTION- an α-hemolytic streptococci, and
streptococcus sanguis play a significant role.
IMMUNOLOGIC ABNORMALITIES
Iron, vitamin B12, folic acid deficiency
p
TRAUMA- due to self –inflicted bites,oral surgical
rocedures,tooth brushing,dental procedures,needle
injections,dental trauma
ENDOCRINE CONDITION-during premenstrual period and
at postovulation period.
7. ETIOLOGY
Cessation of smoking increases the
frequency and
severity of
RAS.
Increased prevalence seen among children of RAS
positive parents (HLA – B 51)
Acute psychological problems appear to precipitate the
attacks of RAS.(more in examination; less in vacation)
8. CLINICAL FEATURES
•Age: second, third and fourth decades.
•Sex: Females>Males
•A higher prevalence has been found in the
higher socioeconomic groups and among
individuals with stress, such as students at
the time of examinations.
9. PRESENTATION
Ulcer begins as a
round or oval
area of erythema
Pin-point central
area of white
ulceration
Next 3-7 days
The ulcer enlarges
laterally
Becomes
saucerized or
cupped out.
As healing
commences
The erythematous
area diminishes
Small punctate red
areas dot thewhite
ulcer bed
10. CLASSIFICATION
Simple aphthous is described when
1. Ulcer recurrences are few
2. Not associated with systemic factors
3. Occur only 2–4 times each year.
Complex aphthous is described when
1. Develop recurrent oral and genital aphthous ulcers
2.When there is a continuous disease activity with new lesions
developing as older lesions heal
3. When ulcers are associated with systemic diseases.
12. AGE- 10-30yr
GENDER- women>men
SITE- common on non-keratinized mucosa e.g –
buccal & labial mucosa, buccal & lingual sulci,
tongue, soft palate, pharynx,gingiva.
APPEARANCE- begins as a single or multiple
superficial erosions covered by greyish – white
removable fibrinopurulent membrane encircled by
erythematous halo.
15. Previously it represent a separate disease entity k/n as
periadenitis mucosa necrotica recurrens (mikulicz’s
scarring aphthae or sutton’s disease)
It is now regarded as severe expression of aphthous
stomatitis.
COMMON SITE- lips, cheeks, tongue, soft palate,
fauces, cause severe pain & dysphagia.
Also involve keratinized mucosa
INCIDENCE – common in HIV patient.
SIZE – Larger than the minor apthous ulcer diameter
more than 10mm.
16. NO.-1-10 in no.
Takes 4-6 weeks to heal.
Heal with scarring
Recurrs in less than a month time.
APPEARANCE- extend deeper and may present as
crater-like ulcers with rolled margins which are
indurated on palpation because of underlying fibrosis.
17.
18. consist of clusters
resemble herpetic lesions.
HERPETIFORM
crops of ulcer
present
ULCERATIONS
• First described by Cooke in 1960 later by Lehner , Brooke
& Sapp
due to tendency to
reccur
RECURRENT
19. SITE- any intra oral site
SIZE-1-3 mm in diameter
APPEARANCE – characterized by crop of small, shallow
ulcers ,that may be joined together and form large
ulcer.
No. – 10 – 100
Healing occur in 1 to 2 weeks.
Heal with scarring.
Lesions persist for 1 to 3 year with short remissions
23. TREATMENT
• Tetracycline mouthrinse : Dosage 250mg per 5ml. It is
usually taken by diluting the tetracycline capsules in 5 ml
of water and is gargled in the mouth four times a day for
5 to 7 days.
This treatment produced a good response in nearly 70 %
of the Patients tested, by reliving the pain, reducing the
size of the lesions and reducing the healing time.
24. TREATMENT
• 5%Amlexanox is an anti- inflammatory, antiallergic used
to treat Recurrent Apthous Ulcers during prodromal
phases.
• It is applied on the Ulcer’s directly 3-4 times a day.
25. TREATMENT
• TRIAMCINOLONE a corticosteroid.
It is used to reduce swelling and ulcers in the mouth.
Applied 3-4 times a day on the ulcer.
26. TREATMENT
• Analgesic’s and Antiseptics such as Deltagel and
Quadragel which contain lignocaine hydrochloride
,metronidazole benzoate,menthol and chlorohexidine
gluconanate helps in reliving pain and help preventing
secondary infections.
27. TREATMENT
• Vitamin B12, Folic Acid Iron
• Not much of positive results are found with administration
of vitamin B12 in patients with Recurrent Apthous Ulcer’s.
28. TREATMENT
• Intralesional injection of steroid
– Triamcinolone acetonide (0.1-0.5 ml/l) or
– Betamethasone propionate and sodium phosphate
• Placing of gauze sponge containing topical steroids on ulcers in
cases of larger ulcers.